Ledger.Open graph →
SEC Form D · filed May 17, 2023

MorphImmune Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WEST LAFAYETTE, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Philip Low, Ph.D · West Lafayette, INDirectorRonald Martell · West Lafayette, INDirectorIsaac Barchas · West Lafayette, INDirectorSunil Singhal, M.D · West Lafayette, INDirectorBill Fathers · Denver, CODirectorDuane Strite · Hephzibah, GADirectorRachel Stack · Denver, CODirectorSimon Barnes · Grand Duchy of Luxembourg, LuxembourgDirectorClay B. Siegall, Ph.D · West Lafayette, INExec · DirectorFranklyn Prendergast, M.D., Ph.D · West Lafayette, INDirectorPatrick Bartels · Fort Lauderdale, FLDirectorJim Grady · Fort Lauderdale, FLDirectorPeter Kim · Irvine, CADirectorKyle Mckuhen · Salt Lake City, UTDirectorClay B. Siegall, Ph.D · West Lafayette, INExec · DirectorFranklyn Prendergast, M.D., Ph.D · West Lafayette, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗